Wyeth, Cordis Stent Patents Are Invalid, Fed. Circ. Rules
The Federal Circuit on Wednesday affirmed a lower court's ruling that two Cordis Corp. and Wyeth Pharmaceuticals Inc. patents covering a drug used in stents are invalid, in a win for...To view the full article, register now.
Already a subscriber? Click here to view full article